IBRN ETF: iShares Neuroscience and Healthcare ETF - Price, Holdings & Analysis
iShares Neuroscience and Healthcare ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About iShares Neuroscience and Healthcare ETF
What is the current price of IBRN?
The latest IBRN price is $39.06. The 52-week range is $25.42–$43.01. IBRN has returned 50.8% over the past 52 weeks.
What is the expense ratio for IBRN?
IBRN's annual expense ratio is 0.47%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does IBRN pay dividends?
Yes, IBRN pays a 0.82% dividend yield. The last ex-dividend date was 2026-12-19. View full dividend history in the Dividends section.
What are the top holdings of IBRN?
IBRN's largest holdings are Dianthus Therapeutics, Inc. (5.1%), Xenon Pharmaceuticals Inc (5.1%), Alkermes plc (4.8%) (combined weight: 15.0%). The fund holds 79 total positions. View the complete portfolio breakdown in the Holdings section.
How does IBRN compare to similar ETFs?
Compare IBRN (0.47% expense ratio, $6M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.